nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosamprenavir—CYP3A4—Calcitriol—psoriasis	0.128	0.191	CbGbCtD
Fosamprenavir—CYP3A4—Methoxsalen—psoriasis	0.0997	0.149	CbGbCtD
Fosamprenavir—CYP3A4—Cholecalciferol—psoriasis	0.066	0.0986	CbGbCtD
Fosamprenavir—CYP3A4—Mycophenolate mofetil—psoriasis	0.0572	0.0855	CbGbCtD
Fosamprenavir—CYP3A4—Triamcinolone—psoriasis	0.0572	0.0855	CbGbCtD
Fosamprenavir—CYP3A4—Betamethasone—psoriasis	0.0491	0.0733	CbGbCtD
Fosamprenavir—CYP3A4—Prednisolone—psoriasis	0.0485	0.0724	CbGbCtD
Fosamprenavir—CYP3A4—Hydrocortisone—psoriasis	0.0459	0.0686	CbGbCtD
Fosamprenavir—CYP3A4—Prednisone—psoriasis	0.0458	0.0683	CbGbCtD
Fosamprenavir—CYP3A4—Cyclosporine—psoriasis	0.0434	0.0648	CbGbCtD
Fosamprenavir—CYP3A4—Dexamethasone—psoriasis	0.0286	0.0427	CbGbCtD
Fosamprenavir—Malnutrition—Cyclosporine—psoriasis	0.0005	0.00151	CcSEcCtD
Fosamprenavir—Nervous system disorder—Mycophenolic acid—psoriasis	0.000494	0.0015	CcSEcCtD
Fosamprenavir—Flatulence—Cyclosporine—psoriasis	0.000492	0.00149	CcSEcCtD
Fosamprenavir—Hyperglycaemia—Betamethasone—psoriasis	0.000491	0.00149	CcSEcCtD
Fosamprenavir—Hyperglycaemia—Dexamethasone—psoriasis	0.000491	0.00149	CcSEcCtD
Fosamprenavir—Skin disorder—Mycophenolic acid—psoriasis	0.00049	0.00148	CcSEcCtD
Fosamprenavir—Malnutrition—Mycophenolate mofetil—psoriasis	0.000488	0.00148	CcSEcCtD
Fosamprenavir—Vomiting—Acitretin—psoriasis	0.000487	0.00147	CcSEcCtD
Fosamprenavir—Vomiting—Fluocinolone Acetonide—psoriasis	0.000486	0.00147	CcSEcCtD
Fosamprenavir—Alanine aminotransferase increased—Prednisone—psoriasis	0.000484	0.00146	CcSEcCtD
Fosamprenavir—Rash—Acitretin—psoriasis	0.000483	0.00146	CcSEcCtD
Fosamprenavir—Dermatitis—Acitretin—psoriasis	0.000483	0.00146	CcSEcCtD
Fosamprenavir—Haemoglobin—Triamcinolone—psoriasis	0.000483	0.00146	CcSEcCtD
Fosamprenavir—Rash—Fluocinolone Acetonide—psoriasis	0.000482	0.00146	CcSEcCtD
Fosamprenavir—Dermatitis—Fluocinolone Acetonide—psoriasis	0.000482	0.00146	CcSEcCtD
Fosamprenavir—Anorexia—Mycophenolic acid—psoriasis	0.000481	0.00145	CcSEcCtD
Fosamprenavir—Haemorrhage—Triamcinolone—psoriasis	0.00048	0.00145	CcSEcCtD
Fosamprenavir—Flatulence—Mycophenolate mofetil—psoriasis	0.00048	0.00145	CcSEcCtD
Fosamprenavir—Headache—Acitretin—psoriasis	0.00048	0.00145	CcSEcCtD
Fosamprenavir—Headache—Fluocinolone Acetonide—psoriasis	0.000479	0.00145	CcSEcCtD
Fosamprenavir—Acute coronary syndrome—Dexamethasone—psoriasis	0.000479	0.00145	CcSEcCtD
Fosamprenavir—Acute coronary syndrome—Betamethasone—psoriasis	0.000479	0.00145	CcSEcCtD
Fosamprenavir—Myocardial infarction—Dexamethasone—psoriasis	0.000476	0.00144	CcSEcCtD
Fosamprenavir—Myocardial infarction—Betamethasone—psoriasis	0.000476	0.00144	CcSEcCtD
Fosamprenavir—Body temperature increased—Hydroxyurea—psoriasis	0.000476	0.00144	CcSEcCtD
Fosamprenavir—Immune system disorder—Hydrocortisone—psoriasis	0.000461	0.00139	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Mycophenolic acid—psoriasis	0.000459	0.00139	CcSEcCtD
Fosamprenavir—Angioedema—Cyclosporine—psoriasis	0.000457	0.00138	CcSEcCtD
Fosamprenavir—Nausea—Acitretin—psoriasis	0.000455	0.00138	CcSEcCtD
Fosamprenavir—Nausea—Fluocinolone Acetonide—psoriasis	0.000454	0.00137	CcSEcCtD
Fosamprenavir—Angioedema—Mycophenolate mofetil—psoriasis	0.000445	0.00135	CcSEcCtD
Fosamprenavir—Malnutrition—Hydrocortisone—psoriasis	0.000444	0.00134	CcSEcCtD
Fosamprenavir—Hypersensitivity—Hydroxyurea—psoriasis	0.000443	0.00134	CcSEcCtD
Fosamprenavir—Neutropenia—Prednisone—psoriasis	0.000443	0.00134	CcSEcCtD
Fosamprenavir—Decreased appetite—Mycophenolic acid—psoriasis	0.000438	0.00133	CcSEcCtD
Fosamprenavir—Haemoglobin—Dexamethasone—psoriasis	0.000438	0.00133	CcSEcCtD
Fosamprenavir—Haemoglobin—Betamethasone—psoriasis	0.000438	0.00133	CcSEcCtD
Fosamprenavir—Haemorrhage—Dexamethasone—psoriasis	0.000436	0.00132	CcSEcCtD
Fosamprenavir—Haemorrhage—Betamethasone—psoriasis	0.000436	0.00132	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Mycophenolic acid—psoriasis	0.000435	0.00132	CcSEcCtD
Fosamprenavir—Fatigue—Mycophenolic acid—psoriasis	0.000435	0.00132	CcSEcCtD
Fosamprenavir—Asthenia—Hydroxyurea—psoriasis	0.000432	0.00131	CcSEcCtD
Fosamprenavir—Hyperglycaemia—Prednisone—psoriasis	0.000428	0.00129	CcSEcCtD
Fosamprenavir—Myalgia—Cyclosporine—psoriasis	0.000425	0.00129	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—psoriasis	0.000423	0.00128	CcSEcCtD
Fosamprenavir—Acute coronary syndrome—Prednisone—psoriasis	0.000417	0.00126	CcSEcCtD
Fosamprenavir—Angioedema—Prednisolone—psoriasis	0.000416	0.00126	CcSEcCtD
Fosamprenavir—Myalgia—Mycophenolate mofetil—psoriasis	0.000415	0.00126	CcSEcCtD
Fosamprenavir—Myocardial infarction—Prednisone—psoriasis	0.000415	0.00125	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Mycophenolic acid—psoriasis	0.000412	0.00125	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—psoriasis	0.000412	0.00125	CcSEcCtD
Fosamprenavir—Diarrhoea—Hydroxyurea—psoriasis	0.000412	0.00125	CcSEcCtD
Fosamprenavir—Angioedema—Hydrocortisone—psoriasis	0.000406	0.00123	CcSEcCtD
Fosamprenavir—Nervous system disorder—Cyclosporine—psoriasis	0.0004	0.00121	CcSEcCtD
Fosamprenavir—Abdominal pain—Mycophenolic acid—psoriasis	0.000399	0.00121	CcSEcCtD
Fosamprenavir—Body temperature increased—Mycophenolic acid—psoriasis	0.000399	0.00121	CcSEcCtD
Fosamprenavir—Dizziness—Hydroxyurea—psoriasis	0.000398	0.0012	CcSEcCtD
Fosamprenavir—Skin disorder—Cyclosporine—psoriasis	0.000396	0.0012	CcSEcCtD
Fosamprenavir—Nervous system disorder—Mycophenolate mofetil—psoriasis	0.00039	0.00118	CcSEcCtD
Fosamprenavir—Anorexia—Cyclosporine—psoriasis	0.000389	0.00118	CcSEcCtD
Fosamprenavir—Skin disorder—Mycophenolate mofetil—psoriasis	0.000386	0.00117	CcSEcCtD
Fosamprenavir—Vomiting—Hydroxyurea—psoriasis	0.000383	0.00116	CcSEcCtD
Fosamprenavir—Angioedema—Triamcinolone—psoriasis	0.000382	0.00116	CcSEcCtD
Fosamprenavir—Haemoglobin—Prednisone—psoriasis	0.000382	0.00115	CcSEcCtD
Fosamprenavir—Haemorrhage—Prednisone—psoriasis	0.00038	0.00115	CcSEcCtD
Fosamprenavir—Rash—Hydroxyurea—psoriasis	0.00038	0.00115	CcSEcCtD
Fosamprenavir—Anorexia—Mycophenolate mofetil—psoriasis	0.000379	0.00115	CcSEcCtD
Fosamprenavir—Dermatitis—Hydroxyurea—psoriasis	0.000379	0.00115	CcSEcCtD
Fosamprenavir—Myalgia—Hydrocortisone—psoriasis	0.000378	0.00114	CcSEcCtD
Fosamprenavir—Headache—Hydroxyurea—psoriasis	0.000377	0.00114	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	0.000376	0.00114	CcSEcCtD
Fosamprenavir—Connective tissue disorder—Prednisone—psoriasis	0.000373	0.00113	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.000372	0.00112	CcSEcCtD
Fosamprenavir—Neutropenia—Methotrexate—psoriasis	0.000371	0.00112	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.000362	0.0011	CcSEcCtD
Fosamprenavir—Asthenia—Mycophenolic acid—psoriasis	0.000362	0.00109	CcSEcCtD
Fosamprenavir—Nausea—Hydroxyurea—psoriasis	0.000358	0.00108	CcSEcCtD
Fosamprenavir—Pruritus—Mycophenolic acid—psoriasis	0.000357	0.00108	CcSEcCtD
Fosamprenavir—Myalgia—Triamcinolone—psoriasis	0.000356	0.00108	CcSEcCtD
Fosamprenavir—Nervous system disorder—Hydrocortisone—psoriasis	0.000355	0.00108	CcSEcCtD
Fosamprenavir—Decreased appetite—Cyclosporine—psoriasis	0.000355	0.00107	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000352	0.00107	CcSEcCtD
Fosamprenavir—Skin disorder—Hydrocortisone—psoriasis	0.000352	0.00107	CcSEcCtD
Fosamprenavir—Fatigue—Cyclosporine—psoriasis	0.000352	0.00106	CcSEcCtD
Fosamprenavir—Stevens-Johnson syndrome—Methotrexate—psoriasis	0.00035	0.00106	CcSEcCtD
Fosamprenavir—Angioedema—Dexamethasone—psoriasis	0.000347	0.00105	CcSEcCtD
Fosamprenavir—Angioedema—Betamethasone—psoriasis	0.000347	0.00105	CcSEcCtD
Fosamprenavir—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000346	0.00105	CcSEcCtD
Fosamprenavir—Anorexia—Hydrocortisone—psoriasis	0.000346	0.00105	CcSEcCtD
Fosamprenavir—Diarrhoea—Mycophenolic acid—psoriasis	0.000345	0.00104	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000343	0.00104	CcSEcCtD
Fosamprenavir—Immune system disorder—Prednisone—psoriasis	0.000343	0.00104	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Cyclosporine—psoriasis	0.000334	0.00101	CcSEcCtD
Fosamprenavir—Dizziness—Mycophenolic acid—psoriasis	0.000333	0.00101	CcSEcCtD
Fosamprenavir—Malnutrition—Prednisone—psoriasis	0.00033	0.001	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.00033	0.000999	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000325	0.000984	CcSEcCtD
Fosamprenavir—Myalgia—Betamethasone—psoriasis	0.000323	0.000977	CcSEcCtD
Fosamprenavir—Myalgia—Dexamethasone—psoriasis	0.000323	0.000977	CcSEcCtD
Fosamprenavir—Abdominal pain—Cyclosporine—psoriasis	0.000322	0.000976	CcSEcCtD
Fosamprenavir—Body temperature increased—Cyclosporine—psoriasis	0.000322	0.000976	CcSEcCtD
Fosamprenavir—Vomiting—Mycophenolic acid—psoriasis	0.000321	0.00097	CcSEcCtD
Fosamprenavir—Haemoglobin—Methotrexate—psoriasis	0.000319	0.000965	CcSEcCtD
Fosamprenavir—Rash—Mycophenolic acid—psoriasis	0.000318	0.000962	CcSEcCtD
Fosamprenavir—Dermatitis—Mycophenolic acid—psoriasis	0.000318	0.000961	CcSEcCtD
Fosamprenavir—Haemorrhage—Methotrexate—psoriasis	0.000317	0.00096	CcSEcCtD
Fosamprenavir—Headache—Mycophenolic acid—psoriasis	0.000316	0.000956	CcSEcCtD
Fosamprenavir—Decreased appetite—Hydrocortisone—psoriasis	0.000315	0.000953	CcSEcCtD
Fosamprenavir—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000315	0.000952	CcSEcCtD
Fosamprenavir—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000315	0.000952	CcSEcCtD
Fosamprenavir—Urinary tract disorder—Methotrexate—psoriasis	0.000313	0.000948	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000313	0.000947	CcSEcCtD
Fosamprenavir—Fatigue—Hydrocortisone—psoriasis	0.000313	0.000946	CcSEcCtD
Fosamprenavir—Urethral disorder—Methotrexate—psoriasis	0.000311	0.000941	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000311	0.000941	CcSEcCtD
Fosamprenavir—Nervous system disorder—Dexamethasone—psoriasis	0.000304	0.000919	CcSEcCtD
Fosamprenavir—Nervous system disorder—Betamethasone—psoriasis	0.000304	0.000919	CcSEcCtD
Fosamprenavir—Angioedema—Prednisone—psoriasis	0.000302	0.000914	CcSEcCtD
Fosamprenavir—Hypersensitivity—Cyclosporine—psoriasis	0.0003	0.000909	CcSEcCtD
Fosamprenavir—Erythema multiforme—Methotrexate—psoriasis	0.0003	0.000908	CcSEcCtD
Fosamprenavir—Nausea—Mycophenolic acid—psoriasis	0.000299	0.000906	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000296	0.000897	CcSEcCtD
Fosamprenavir—Anorexia—Dexamethasone—psoriasis	0.000295	0.000893	CcSEcCtD
Fosamprenavir—Anorexia—Betamethasone—psoriasis	0.000295	0.000893	CcSEcCtD
Fosamprenavir—Cardiac disorder—Methotrexate—psoriasis	0.000294	0.000891	CcSEcCtD
Fosamprenavir—Fatigue—Triamcinolone—psoriasis	0.000294	0.00089	CcSEcCtD
Fosamprenavir—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000293	0.000887	CcSEcCtD
Fosamprenavir—Asthenia—Cyclosporine—psoriasis	0.000293	0.000885	CcSEcCtD
Fosamprenavir—Pruritus—Cyclosporine—psoriasis	0.000289	0.000873	CcSEcCtD
Fosamprenavir—Immune system disorder—Methotrexate—psoriasis	0.000287	0.000867	CcSEcCtD
Fosamprenavir—Abdominal pain—Hydrocortisone—psoriasis	0.000287	0.000867	CcSEcCtD
Fosamprenavir—Body temperature increased—Hydrocortisone—psoriasis	0.000287	0.000867	CcSEcCtD
Fosamprenavir—Asthenia—Mycophenolate mofetil—psoriasis	0.000285	0.000864	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000282	0.000854	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000282	0.000854	CcSEcCtD
Fosamprenavir—Pruritus—Mycophenolate mofetil—psoriasis	0.000281	0.000852	CcSEcCtD
Fosamprenavir—Myalgia—Prednisone—psoriasis	0.000281	0.000851	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000279	0.000845	CcSEcCtD
Fosamprenavir—Diarrhoea—Cyclosporine—psoriasis	0.000279	0.000844	CcSEcCtD
Fosamprenavir—Malnutrition—Methotrexate—psoriasis	0.000276	0.000836	CcSEcCtD
Fosamprenavir—Hypersensitivity—Prednisolone—psoriasis	0.000273	0.000827	CcSEcCtD
Fosamprenavir—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000272	0.000824	CcSEcCtD
Fosamprenavir—Body temperature increased—Triamcinolone—psoriasis	0.00027	0.000816	CcSEcCtD
Fosamprenavir—Dizziness—Cyclosporine—psoriasis	0.00027	0.000816	CcSEcCtD
Fosamprenavir—Decreased appetite—Dexamethasone—psoriasis	0.000269	0.000815	CcSEcCtD
Fosamprenavir—Decreased appetite—Betamethasone—psoriasis	0.000269	0.000815	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Betamethasone—psoriasis	0.000267	0.000809	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000267	0.000809	CcSEcCtD
Fosamprenavir—Hypersensitivity—Hydrocortisone—psoriasis	0.000267	0.000808	CcSEcCtD
Fosamprenavir—Fatigue—Dexamethasone—psoriasis	0.000267	0.000808	CcSEcCtD
Fosamprenavir—Fatigue—Betamethasone—psoriasis	0.000267	0.000808	CcSEcCtD
Fosamprenavir—Nervous system disorder—Prednisone—psoriasis	0.000264	0.0008	CcSEcCtD
Fosamprenavir—Dizziness—Mycophenolate mofetil—psoriasis	0.000263	0.000796	CcSEcCtD
Fosamprenavir—Skin disorder—Prednisone—psoriasis	0.000262	0.000793	CcSEcCtD
Fosamprenavir—Asthenia—Hydrocortisone—psoriasis	0.00026	0.000787	CcSEcCtD
Fosamprenavir—Vomiting—Cyclosporine—psoriasis	0.000259	0.000785	CcSEcCtD
Fosamprenavir—Rash—Cyclosporine—psoriasis	0.000257	0.000778	CcSEcCtD
Fosamprenavir—Anorexia—Prednisone—psoriasis	0.000257	0.000778	CcSEcCtD
Fosamprenavir—Dermatitis—Cyclosporine—psoriasis	0.000257	0.000777	CcSEcCtD
Fosamprenavir—Pruritus—Hydrocortisone—psoriasis	0.000256	0.000776	CcSEcCtD
Fosamprenavir—Headache—Cyclosporine—psoriasis	0.000256	0.000773	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Dexamethasone—psoriasis	0.000253	0.000766	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Betamethasone—psoriasis	0.000253	0.000766	CcSEcCtD
Fosamprenavir—Vomiting—Mycophenolate mofetil—psoriasis	0.000253	0.000765	CcSEcCtD
Fosamprenavir—Hypersensitivity—Triamcinolone—psoriasis	0.000251	0.000761	CcSEcCtD
Fosamprenavir—Rash—Mycophenolate mofetil—psoriasis	0.000251	0.000759	CcSEcCtD
Fosamprenavir—Dermatitis—Mycophenolate mofetil—psoriasis	0.000251	0.000758	CcSEcCtD
Fosamprenavir—Headache—Mycophenolate mofetil—psoriasis	0.000249	0.000754	CcSEcCtD
Fosamprenavir—Diarrhoea—Hydrocortisone—psoriasis	0.000248	0.00075	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Prednisone—psoriasis	0.000246	0.000743	CcSEcCtD
Fosamprenavir—Dizziness—Prednisolone—psoriasis	0.000245	0.000743	CcSEcCtD
Fosamprenavir—Asthenia—Triamcinolone—psoriasis	0.000245	0.000741	CcSEcCtD
Fosamprenavir—Abdominal pain—Betamethasone—psoriasis	0.000245	0.000741	CcSEcCtD
Fosamprenavir—Abdominal pain—Dexamethasone—psoriasis	0.000245	0.000741	CcSEcCtD
Fosamprenavir—Body temperature increased—Betamethasone—psoriasis	0.000245	0.000741	CcSEcCtD
Fosamprenavir—Body temperature increased—Dexamethasone—psoriasis	0.000245	0.000741	CcSEcCtD
Fosamprenavir—Nausea—Cyclosporine—psoriasis	0.000242	0.000733	CcSEcCtD
Fosamprenavir—Pruritus—Triamcinolone—psoriasis	0.000241	0.000731	CcSEcCtD
Fosamprenavir—Dizziness—Hydrocortisone—psoriasis	0.00024	0.000725	CcSEcCtD
Fosamprenavir—Nausea—Mycophenolate mofetil—psoriasis	0.000236	0.000715	CcSEcCtD
Fosamprenavir—Myalgia—Methotrexate—psoriasis	0.000235	0.000711	CcSEcCtD
Fosamprenavir—Decreased appetite—Prednisone—psoriasis	0.000234	0.000709	CcSEcCtD
Fosamprenavir—Rash—Prednisolone—psoriasis	0.000234	0.000708	CcSEcCtD
Fosamprenavir—Dermatitis—Prednisolone—psoriasis	0.000234	0.000707	CcSEcCtD
Fosamprenavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.000234	0.000706	CcSEcCtD
Fosamprenavir—Fatigue—Prednisone—psoriasis	0.000233	0.000704	CcSEcCtD
Fosamprenavir—Headache—Prednisolone—psoriasis	0.000233	0.000703	CcSEcCtD
Fosamprenavir—Vomiting—Hydrocortisone—psoriasis	0.00023	0.000697	CcSEcCtD
Fosamprenavir—Rash—Hydrocortisone—psoriasis	0.000229	0.000692	CcSEcCtD
Fosamprenavir—Dermatitis—Hydrocortisone—psoriasis	0.000228	0.000691	CcSEcCtD
Fosamprenavir—Headache—Hydrocortisone—psoriasis	0.000227	0.000687	CcSEcCtD
Fosamprenavir—Dizziness—Triamcinolone—psoriasis	0.000226	0.000683	CcSEcCtD
Fosamprenavir—Asthenia—Betamethasone—psoriasis	0.000222	0.000672	CcSEcCtD
Fosamprenavir—Asthenia—Dexamethasone—psoriasis	0.000222	0.000672	CcSEcCtD
Fosamprenavir—Nervous system disorder—Methotrexate—psoriasis	0.000221	0.000669	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Prednisone—psoriasis	0.000221	0.000667	CcSEcCtD
Fosamprenavir—Nausea—Prednisolone—psoriasis	0.00022	0.000667	CcSEcCtD
Fosamprenavir—Pruritus—Betamethasone—psoriasis	0.000219	0.000663	CcSEcCtD
Fosamprenavir—Pruritus—Dexamethasone—psoriasis	0.000219	0.000663	CcSEcCtD
Fosamprenavir—Skin disorder—Methotrexate—psoriasis	0.000219	0.000662	CcSEcCtD
Fosamprenavir—Vomiting—Triamcinolone—psoriasis	0.000217	0.000657	CcSEcCtD
Fosamprenavir—Nausea—Hydrocortisone—psoriasis	0.000215	0.000651	CcSEcCtD
Fosamprenavir—Rash—Triamcinolone—psoriasis	0.000215	0.000651	CcSEcCtD
Fosamprenavir—Dermatitis—Triamcinolone—psoriasis	0.000215	0.000651	CcSEcCtD
Fosamprenavir—Anorexia—Methotrexate—psoriasis	0.000215	0.00065	CcSEcCtD
Fosamprenavir—Headache—Triamcinolone—psoriasis	0.000214	0.000647	CcSEcCtD
Fosamprenavir—Body temperature increased—Prednisone—psoriasis	0.000213	0.000645	CcSEcCtD
Fosamprenavir—Abdominal pain—Prednisone—psoriasis	0.000213	0.000645	CcSEcCtD
Fosamprenavir—Diarrhoea—Dexamethasone—psoriasis	0.000212	0.000641	CcSEcCtD
Fosamprenavir—Diarrhoea—Betamethasone—psoriasis	0.000212	0.000641	CcSEcCtD
Fosamprenavir—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000205	0.000621	CcSEcCtD
Fosamprenavir—Dizziness—Dexamethasone—psoriasis	0.000205	0.00062	CcSEcCtD
Fosamprenavir—Dizziness—Betamethasone—psoriasis	0.000205	0.00062	CcSEcCtD
Fosamprenavir—Nausea—Triamcinolone—psoriasis	0.000203	0.000613	CcSEcCtD
Fosamprenavir—Hypersensitivity—Prednisone—psoriasis	0.000199	0.000601	CcSEcCtD
Fosamprenavir—Vomiting—Dexamethasone—psoriasis	0.000197	0.000596	CcSEcCtD
Fosamprenavir—Vomiting—Betamethasone—psoriasis	0.000197	0.000596	CcSEcCtD
Fosamprenavir—Decreased appetite—Methotrexate—psoriasis	0.000196	0.000593	CcSEcCtD
Fosamprenavir—Rash—Dexamethasone—psoriasis	0.000195	0.000591	CcSEcCtD
Fosamprenavir—Rash—Betamethasone—psoriasis	0.000195	0.000591	CcSEcCtD
Fosamprenavir—Dermatitis—Dexamethasone—psoriasis	0.000195	0.00059	CcSEcCtD
Fosamprenavir—Dermatitis—Betamethasone—psoriasis	0.000195	0.00059	CcSEcCtD
Fosamprenavir—Gastrointestinal disorder—Methotrexate—psoriasis	0.000195	0.000589	CcSEcCtD
Fosamprenavir—Fatigue—Methotrexate—psoriasis	0.000194	0.000588	CcSEcCtD
Fosamprenavir—Headache—Betamethasone—psoriasis	0.000194	0.000587	CcSEcCtD
Fosamprenavir—Headache—Dexamethasone—psoriasis	0.000194	0.000587	CcSEcCtD
Fosamprenavir—Asthenia—Prednisone—psoriasis	0.000193	0.000585	CcSEcCtD
Fosamprenavir—Pruritus—Prednisone—psoriasis	0.000191	0.000577	CcSEcCtD
Fosamprenavir—Diarrhoea—Prednisone—psoriasis	0.000185	0.000558	CcSEcCtD
Fosamprenavir—Gastrointestinal pain—Methotrexate—psoriasis	0.000184	0.000558	CcSEcCtD
Fosamprenavir—Nausea—Betamethasone—psoriasis	0.000184	0.000557	CcSEcCtD
Fosamprenavir—Nausea—Dexamethasone—psoriasis	0.000184	0.000557	CcSEcCtD
Fosamprenavir—Dizziness—Prednisone—psoriasis	0.000178	0.00054	CcSEcCtD
Fosamprenavir—Body temperature increased—Methotrexate—psoriasis	0.000178	0.000539	CcSEcCtD
Fosamprenavir—Abdominal pain—Methotrexate—psoriasis	0.000178	0.000539	CcSEcCtD
Fosamprenavir—Vomiting—Prednisone—psoriasis	0.000171	0.000519	CcSEcCtD
Fosamprenavir—Rash—Prednisone—psoriasis	0.00017	0.000515	CcSEcCtD
Fosamprenavir—Dermatitis—Prednisone—psoriasis	0.00017	0.000514	CcSEcCtD
Fosamprenavir—Headache—Prednisone—psoriasis	0.000169	0.000511	CcSEcCtD
Fosamprenavir—Hypersensitivity—Methotrexate—psoriasis	0.000166	0.000502	CcSEcCtD
Fosamprenavir—Asthenia—Methotrexate—psoriasis	0.000162	0.000489	CcSEcCtD
Fosamprenavir—Nausea—Prednisone—psoriasis	0.00016	0.000485	CcSEcCtD
Fosamprenavir—Pruritus—Methotrexate—psoriasis	0.000159	0.000482	CcSEcCtD
Fosamprenavir—Diarrhoea—Methotrexate—psoriasis	0.000154	0.000467	CcSEcCtD
Fosamprenavir—Dizziness—Methotrexate—psoriasis	0.000149	0.000451	CcSEcCtD
Fosamprenavir—Vomiting—Methotrexate—psoriasis	0.000143	0.000434	CcSEcCtD
Fosamprenavir—Rash—Methotrexate—psoriasis	0.000142	0.00043	CcSEcCtD
Fosamprenavir—Dermatitis—Methotrexate—psoriasis	0.000142	0.00043	CcSEcCtD
Fosamprenavir—Headache—Methotrexate—psoriasis	0.000141	0.000427	CcSEcCtD
Fosamprenavir—Nausea—Methotrexate—psoriasis	0.000134	0.000405	CcSEcCtD
